These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 21351468

  • 1. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms].
    Liu JP, Wei HB, Zheng ZH, Guo WP, Fang JF.
    Yao Xue Xue Bao; 2009 Dec; 44(12):1353-8. PubMed ID: 21351468
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib increases retinoid sensitivity in human colon cancer cell lines.
    Liu JP, Wei HB, Zheng ZH, Guo WP, Fang JF.
    Cell Mol Biol Lett; 2010 Sep; 15(3):440-50. PubMed ID: 20496179
    [Abstract] [Full Text] [Related]

  • 3. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 5. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK, Park JS, Kim HS, Jun HJ, Kim GE, Suh CO, Yun YS, Pyo H.
    Cancer Res; 2005 Oct 15; 65(20):9501-9. PubMed ID: 16230415
    [Abstract] [Full Text] [Related]

  • 6. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 7. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 8. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 02; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 9. Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels.
    Bijman MN, Hermelink CA, van Berkel MP, Laan AC, Janmaat ML, Peters GJ, Boven E.
    Biochem Pharmacol; 2008 Jan 15; 75(2):427-37. PubMed ID: 17936723
    [Abstract] [Full Text] [Related]

  • 10. Role of leukotriene B4 in celecoxib-mediated anticancer effect.
    Gao P, Guan L, Zheng J.
    Biochem Biophys Res Commun; 2010 Nov 12; 402(2):308-11. PubMed ID: 20937254
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L, Chen W, Xie X, He Y, Bai X.
    Exp Oncol; 2008 Mar 12; 30(1):42-51. PubMed ID: 18438340
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2007 Feb 12; 82(2):229-38. PubMed ID: 17207548
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
    Sugimoto T, Bartholomeusz C, Tari AM, Ueno NT.
    Breast Cancer Res; 2007 Feb 12; 9(4):R41. PubMed ID: 17612393
    [Abstract] [Full Text] [Related]

  • 14. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM, Roy KR, Anilkumar K, Aparna A, Reddy GV, Reddanna P.
    Leuk Res; 2008 Jun 12; 32(6):855-64. PubMed ID: 18083230
    [Abstract] [Full Text] [Related]

  • 15. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H, Ye Y, Bai Z, Wang S.
    Dig Dis Sci; 2008 Aug 12; 53(8):2195-203. PubMed ID: 18320325
    [Abstract] [Full Text] [Related]

  • 16. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
    Li WZ, Wang XY, Ding YQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 12; 29(3):466-8. PubMed ID: 19304526
    [Abstract] [Full Text] [Related]

  • 17. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2008 Jul 15; 76(2):179-87. PubMed ID: 18547544
    [Abstract] [Full Text] [Related]

  • 18. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.
    Yan YX, Li WZ, Huang YQ, Liao WX.
    Prostaglandins Other Lipid Mediat; 2012 Jan 15; 97(1-2):29-35. PubMed ID: 21835258
    [Abstract] [Full Text] [Related]

  • 19. A celecoxib derivative potently inhibits proliferation of colon adenocarcinoma cells by induction of apoptosis.
    Kusunoki N, Ito T, Sakurai N, Handa H, Kawai S.
    Anticancer Res; 2006 Jan 15; 26(5A):3229-36. PubMed ID: 17094434
    [Abstract] [Full Text] [Related]

  • 20. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.
    Gallouet AS, Travert M, Bresson-Bepoldin L, Guilloton F, Pangault C, Caulet-Maugendre S, Lamy T, Tarte K, Guillaudeux T.
    Clin Cancer Res; 2014 May 15; 20(10):2663-73. PubMed ID: 24637636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.